REGN - Regeneron Eylea generics approved by FDA
2024-05-20 12:16:50 ET
More on Regeneron Pharmaceuticals
- Regeneron wins temporary restraining order preventing Eylea generic launch (update)
- Evercore says biotech ‘winter is finally thawing’
- Regeneron Pharmaceuticals Inc (REGN) RBC Capital Markets Global Healthcare Conference (Transcript)
- Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks
- Regeneron Pharmaceuticals, Inc. (REGN) Q1 2024 Earnings Call Transcript